18 October 2021Canntab Therapeutics (PILL.C) Enters Agreement with 36Eight TechnologiesKieran Robertson PILL.C Canntab Therapeutics (PILL.C) announced today that it has reached an agreement with 36Eight Technologies (“36Eight”), whereby “36Eight” will list, market, and support all of Canntab’s market-exclusive and patent-protected solid…